Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Ipilimumab × CNS × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2 Thoracic 1 Lymphoid 1 Gynecologic 1 Genitourinary 1 Dermatologic 1 CNS 1

Conditions

Brain Neoplasms 21 Melanoma 16 Glioblastoma 10 Neuroblastoma 6 Glioma 4 Carcinoma, Non-Small-Cell Lung 4 Carcinoma, Transitional Cell 3 Carcinoma, Renal Cell 3 Wilms Tumor 2 Seminoma 2 Rhabdomyosarcoma 2 Osteosarcoma 2 Neoplasm Metastasis 2 Meningioma 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Hodgkin Disease 2 Gliosarcoma 2 Central Nervous System Neoplasms 2 Astrocytoma 2 Xeroderma Pigmentosum 1 Vulvar Neoplasms 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Turcot syndrome 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Testicular Neoplasms 1 Teratoma, Testicular 1 Teratoma 1

Interventions

Temozolomide 22 Bevacizumab 18 Cyclophosphamide 7 Lomustine 6 Irinotecan 6 Carboplatin 6 3-Iodobenzylguanidine 6 Topotecan 5 Radiotherapy 5 Radiosurgery 4 Nivolumab 4 Filgrastim 4 Everolimus 4 fludarabine phosphate 3 Vincristine 3 Sirolimus 3 IL13-PE38 3 Etoposide 3 Drug Therapy 3 Busulfan 3 Antilymphocyte Serum 3 thymoglobulin 2 sonidegib 2 ribociclib 2 pembrolizumab 2 paclitaxel-Angiopep-2 conjugate 2 olaparib 2 fluorodopa F 18 2 fludarabine 2 etoposide phosphate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03233152 2025-11-21

GlitIpNi

Universitair Ziekenhuis Brussel

Phase 1/2 Active not recruiting

Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡